跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ETHACRYNATE SODIUM FOR INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ETHACRYNATE SODIUM FOR INJECTION USP
Authorized
STANDARD
ETHACRYNATE SODIUM FOR INJECTION USP
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d5d0e9381634ea0e
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
d5d0e9381634ea0e
Drug Approval Canada Name
ETHACRYNATE SODIUM FOR INJECTION USP
Product Name
ETHACRYNATE SODIUM FOR INJECTION USP
Status
Dormant
Status Date
2024-06-27
Original Market Date
2018-03-29
Din
02469456
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
40:28.08
Atc Original
C03CC01 ETACRYNIC ACID
Atc Name
c 03 cc 01
Aig Number
0101703001
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
ETHACRYNIC ACID (ETHACRYNATE SODIUM)
50 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d5d0e9381634ea0e
Type
Standard
Back to Health Canada Approvals